Heart & Lung: The Journal of Acute and Critical Care
Volume 38, Issue 1 , Pages 34-47 , January 2009

Chronic obstructive pulmonary disease, anxiety, and depression: State of the science

  • Heidi Putman-Casdorph, DNSc, RN

      Affiliations

    • Corresponding Author InformationCorresponding author: Heidi Putman-Casdorph, DNSc, RN, West Virginia University, School of Nursing, PO Box 9630, Morgantown, WV 26506
    • ,
  • Susan McCrone, PhD, RN, APRN, BC

References 

  1. Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127:1205–1211
  2. Chronic Obstructive Pulmonary Disease Fact Sheet. American Lung Association; August 2006;www.lungusa.orgAccessed March 8, 2007
  3. COPD International. www.copd-international.comAccessed July 4, 2007
  4. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;174:532–555
  5. Han MK, Postma D, Mannino DM, et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007;176:1179–1184
  6. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28:523–532
  7. O'Neill ES. Illness representation and coping of women with chronic obstructive pulmonary disease: a pilot study. Heart Lung. 2002;31:295–302
  8. Yellowlees PM, Alpers JH, Bowden JJ, Bryant GD, Ruffin RE. Psychiatric morbidity in patients with chronic airflow obstruction. Med J Aust. 1987;146:305–307
  9. Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med. 2003;65:963–970
  10. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS Task Force. Eur Respir J. 2004;23:932–946
  11. Physician's desk reference. In: Montvale, NJ: Thomson Healthcare; 2007;p. 61
  12. Brown ES, Chandler PA. Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry. 2001;3:17–21
  13. Foster JM, Aucott L, van der Werf RH, et al. High patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: a cross- sectional analysis. Respir Med. 2006;100:1318–1336
  14. Beck AT, Emery G, Greenberg R. Anxiety disorders and phobias: a cognitive perspective. New York, NY: Basic Books; 2005;
  15. Spielberger CD. Theory and research on anxiety. Academic Press: New York; 1966;
  16. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–55
  17. McNair DM, Lorr M. An analysis of mood in neurotics. J Abn Soc Psychol. 1964;69:620–627
  18. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psych Meas. 1977;1:385–401
  19. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370
  20. Beck AT. A systematic investigation of depression. Compr Psychiatry. 1961;2:163–170
  21. Aghanwa HS, Erhabor GE. Specific psychiatric morbidity among patients with chronic obstructive pulmonary disease in a Nigerian general hospital. J Psychosom Res. 2001;50:179–183
  22. Dowson C, Laing R, Barraclough R, et al. The use of the Hospital Anxiety and Depression scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. N Z Med J. 2001;114:447–449
  23. Guell R, Resqueti V, Sangenis M, et al. Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest. 2006;129:899–904
  24. Karajgi B, Rifkin A, Doddi S, Kolli R. The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Am J Psychiatry. 1990;147:200–201
  25. Porzelius J, Vest M, Nochomovitz M. Respiratory function, cognitions, and panic in chronic obstructive pulmonary patients. Behav Res Ther. 1992;30:75–77
  26. Gift AG, Moore T, Soeken K. Relaxation to reduce dyspnea and anxiety in COPD patients. Nurs Res. 1992;41:242–246
  27. Beekman AT, Copeland JR, Prince MJ. Review of community prevalence of depression in later life. Br J Psychiatry. 1999;174:307–311
  28. Light RW, Merrill EJ, Despars JA, Gordon GH, Mutalipassi LR. Prevalence of depression and anxiety in patients with COPD. Chest. 1985;87:35–38
  29. Borson S, Claypoole K, McDonald G. Depression and chronic obstructive pulmonary disease: treatment trials. Semin Clin Neuropsychiatry. 1998;3:115–130
  30. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence and validation of the BASDEC screening questionnaire. Int J Psychiatry. 2000;15:1090–1096
  31. Lenfant C. Medical and psychiatric illness: different but concurrent!. Metabolism. 2005;54:53–54
  32. Kunik M, Azzam P, Souchek J, et al. A practical screening tool for anxiety and depression in patients with chronic breathing disorders. Psychosomatics. 2007;48:16–21
  33. Roundy K, Cully J, Stanley M, et al. Are anxiety and depression addressed in primary care patients with chronic obstructive pulmonary disease? (A chart review). J Clin Psychiatry. 2005;7:213–220
  34. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167:60–67
  35. Weaver TE, Narsavage GL. Physiological variables related to functional status in chronic obstructive pulmonary disease. Nurs Res. 1992;41:286–291
  36. Weaver TE, Richmond TS, Narsavage GL. An explanatory model of functional status in chronic obstructive pulmonary disease. Nurs Res. 1997;46:26–31
  37. Ormel J, Kempen G, Deeg D, Brilman E, Sondersen E, Relyveld J. Functioning, well-being, and health perception in late middle-age and older people: comparing the effects of depressive symptoms and chronic medical conditions. J Am Geriatr Soc. 1998;46:39–48
  38. Koenig HG, Kuchibhatla M. Use of health services by hospitalized medically ill depressed elderly patients. Am J Psychiatry. 1998;155:871–877
  39. Seung-Kim HF, Kunik ME, Molinari VA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2000;41:465–471
  40. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–2107
  41. Van Manen JG, Bindels PJE, Ijzermans CJ, van der Zee JS, Bottems BJAM, Schade E. Prevalence of comorbidity inpatients with chronic airway obstruction and controls over the age of 40. J Clin Epidemiol. 2001;54:287–293
  42. Stage KB, Middleboe T, Pisinger C. Depression and chronic obstructive pulmonary disease (COPD) (Impact on survival). Acta Psychiatr Scand. 2005;111:320–323
  43. Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, VanTuinen C. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics. 1992;33:190–201
  44. Argyropoulou P, Patakas D, Koukou A, Vasiliadis P, Georgopoulos D. Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration. 1993;60:216–220
  45. Evans M, Hammond M, Wilson K, Lye M, Copeland J. Placebo controlled treatment trial of depression in elderly physically ill patients. Int J Geriatr Psychiatry. 1997;12:817–824
  46. Smoller JW, Pollack MH, Systrom D, Kradin RL. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics. 1998;39:24–29
  47. Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Psychiatry. 2001;16:451–454
  48. Lacasse Y, Beaudoin L, Rousseau L, Maltais F. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis. 2004;61:140–147
  49. Eiser N, Harte R, Karvounis S, Phillips C, Isaac M. Effect of treating depression on quality of life and exercise tolerance in severe COPD. COPD. 2005;2:233–241
  50. Singh NP, Despars JA, Stansbury DW, Avalos K, Light RW. Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest. 1993;103:800–804
  51. Papp LA, Weiss JR, Greenberg HE, et al. Sertraline for chronic obstructive pulmonary disease and co-morbid anxiety and mood disorders (Letter to the Editor). Am J Psychiatry. 1995;152:1531
  52. Raji MA. On depression, antidepressant medications, and resuscitation preferences in COPD patients. Chest. 2006;129:211
  53. Tashkin D, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomized trial. Lancet. 2001;357:1571–1575
  54. Versiani M, Moreno R, Ramakers-van Moorsel CJ, et al. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients. CNS Drugs. 2005;19:137–146
  55. Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. J Health Psychol. 1998;17:232–240
  56. Kunik ME, Braun U, Stanley MA, et al. One session cognitive behavioral therapy for elderly patients with chronic pulmonary disease. Psychol Med. 2001;31:717–723
  57. de Godoy D, de Godoy R. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2003;84:1154–1157
  58. Lisansky D, Hendel-Clough D. A cognitive-behavioral self-help educational program for patients with COPD: a pilot study. Psychother Psychosom. 1996;65:97–101
  59. Eiser N, West C, Evans S, Jeffers A, Quirk F. Effects of psychotherapy in moderately severe COPD: a pilot study. Eur Respir J. 1997;10:1581–1584
  60. Alexopoulos GS, Sirey JA, Raue PJ, Kanellopoulos D, Clark TE, Novitch R. Outcomes of depressed patients undergoing inpatient pulmonary rehabilitation. Am J Geriatr Psychiatry. 2006;14:466–475
  61. Sassi-Dambron DE, Eakin EG, Ries AL, Kaplan RM. Treatment of dyspnea in COPD: a controlled clinical trial of dyspnea management strategies. Chest. 1995;107:724–729
  62. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med. 1995;122:823–832
  63. Withers NJ, Rudkin ST, White RJ. Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation. J Cardiopulm Rehabil. 1999;19:362–365
  64. Kozora E, Tran ZV, Make B. Neurobehavioral improvement after brief rehabilitation in patients with chronic obstructive pulmonary disease. J Cardiopulmon Rehabil. 2002;22:426–430
  65. Nguyen HQ, Carrieri-Kohlman V. Dyspnea self-management in patients with chronic obstructive pulmonary disease: moderating effects of depressed mood. Psychosomatics. 2005;46:402–410
  66. Kayahan B, Karapolat H, Atyntoprak E, Atasever A, Ozturk O. Psychological outcomes of an outpatient pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease. Respir Med. 2006;100:1050–1057
  67. Derogatis LR, Yevzeroff H, Wittelsberger B. Social class, psychological disorder and the nature of the psychopathological indicator. J Consult Clin Psychol. 1975;43:183–191
  68. Paz-Diaz H, de Oca M, Lopez J, Celli B. Pulmonary rehabilitation improves depression, anxiety, dyspnea, and health status in patients with COPD. Am J Phys Med Rehabil. 2006;86:30–36
  69. Rost K, Nutting P, Smith JL, Elliot CE, Dickinson M. Managing depression as a chronic disease: a randomized trial of ongoing treatment in primary care. BMJ. 2002;325:934–937
  70. Unutzer J, Katon W, Callahan CM, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288:2836–2845
  71. McGeoch G, Willsman K, Dowson C, Town G, Frampton C, McCartin F. Self management plans in the primary care of patients with chronic obstructive pulmonary disease. Respirology. 2006;11:611–618

PII: S0147-9563(08)00024-1

doi: 10.1016/j.hrtlng.2008.02.005

Heart & Lung: The Journal of Acute and Critical Care
Volume 38, Issue 1 , Pages 34-47 , January 2009

Article Tools